Home›People›Nancy Pryer
NP

Nancy Pryer

Executive officer at Ambagon Therapeutics.

Executive
Updated Oct 27, 2026·Latest SEC filing Jun 1, 2022·Suggest an edit

About Nancy Pryer

Form D filings for Ambagon Therapeutics from 2021 to 2022 list Nancy Pryer as executive officer.

Nancy Pryer first appears on SEC filings in 2021.

Experience

This experience comes from SEC filings. The years are when the filings name Nancy Pryer in the role, so the role may have started earlier or lasted longer.

Ambagon Therapeutics Inc.
Executive officer
2021 – 2022 · Eindhoven, Netherlands
Develops experimental cancer drugs that stabilize interactions between proteins.

Key Colleagues at Startups

The people Nancy Pryer works with at each company, as listed on that company's latest Form D.

Ambagon Therapeutics Inc. · Form D/A, Jun 1, 2022
JS
Josh Seidenfeld
Executive officer
MA
PD
Peter Dudek
Director
RB
Christian Ottmann
Christian Ottmann
Co-Founder & Chief Executive Officer
AR
MM
Melissa McCracken
Partner, Nextech Invest and director
BM
Bryan Miller
Executive officer
SC
Scott Clarke
Chief Executive Officer and director

Sources

  1. SECAmbagon Therapeutics Inc. Form D/A, filed Jun 1, 2022